Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19

Daisuke Kasugai, Taku Tanaka, Takako Suzuki, Yoshinori Ito, Kazuki Nishida, Masayuki Ozaki, Takeo Kutsuna, Toshiki Yokoyama, Hitoshi Kaneko, Ryo Ogata, Ryohei Matsui, Takahiro Goshima, Hiroshi Hamada, Azusa Ishii, Yusuke Kodama, Naruhiro Jingushi, Ken Ishikura, Ryo Kamidani, Masashi Tada, Hideshi Okada, Takanori Yamamoto, Yukari Goto

Open source

DOI: 10.3389/fimmu.2024.1337070
Published: 2024-03-11
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1337070,
  title = {Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19},
  author = {Daisuke Kasugai and Taku Tanaka and Takako Suzuki and Yoshinori Ito and Kazuki Nishida and Masayuki Ozaki and Takeo Kutsuna and Toshiki Yokoyama and Hitoshi Kaneko and Ryo Ogata and Ryohei Matsui and Takahiro Goshima and Hiroshi Hamada and Azusa Ishii and Yusuke Kodama and Naruhiro Jingushi and Ken Ishikura and Ryo Kamidani and Masashi Tada and Hideshi Okada and Takanori Yamamoto and Yukari Goto},
  year = {2024},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2024.1337070},
  url = {https://doi.org/10.3389/fimmu.2024.1337070}
}

RIS

TY  - JOUR
TI  - Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
AU  - Daisuke Kasugai
AU  - Taku Tanaka
AU  - Takako Suzuki
AU  - Yoshinori Ito
AU  - Kazuki Nishida
AU  - Masayuki Ozaki
AU  - Takeo Kutsuna
AU  - Toshiki Yokoyama
AU  - Hitoshi Kaneko
AU  - Ryo Ogata
AU  - Ryohei Matsui
AU  - Takahiro Goshima
AU  - Hiroshi Hamada
AU  - Azusa Ishii
AU  - Yusuke Kodama
AU  - Naruhiro Jingushi
AU  - Ken Ishikura
AU  - Ryo Kamidani
AU  - Masashi Tada
AU  - Hideshi Okada
AU  - Takanori Yamamoto
AU  - Yukari Goto
PY  - 2024
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2024.1337070
UR  - https://doi.org/10.3389/fimmu.2024.1337070
ER  -

APA

Kasugai, D., Tanaka, T., Suzuki, T., Ito, Y., Nishida, K., Ozaki, M., Kutsuna, T., Yokoyama, T., Kaneko, H., Ogata, R., Matsui, R., Goshima, T., Hamada, H., Ishii, A., Kodama, Y., Jingushi, N., Ishikura, K., Kamidani, R., Tada, M., Okada, H., Yamamoto, T., & Goto, Y. (2024). Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1337070

Source records

crossref · retrieved 2026-09-27T13:39:39.938Z